Investigation of efficacy and safety of NT201 in Upper Facial lines

• Research type

  Research Study

• Full title

  A prospective, randomized, double-blind, placebo-controlled, multicenter study with an open-label extension period to investigate the efficacy and safety of NT 201 in the combined treatment of upper facial lines (horizontal forehead lines, glabellar frown lines, and lateral periorbital lines)

• IRAS ID

  104199

• Contact name

  Simon Connolly

• Sponsor organisation

  Merz Pharmaceuticals GmbH

• Eudract number

  2011-005887-20

• Research summary

  Study with two injections (one injection with placebo or drug, one injection with drug) to investigate the efficacy and safety of NT 201 (active ingredient: Botulinum (neuro)toxin type A, free from complexing proteins) in the combined treatment of wrinkles in the upper face.

• REC name

  Scotland A REC

• REC reference

  12/SS/0080

• Date of REC Opinion

  11 Jun 2012

• REC opinion

  Further Information Favourable Opinion